CAI
Caris Life Sciences, Inc. (CAI)
NASDAQ · Healthcare
Caris Life Sciences, Inc. annual/quarterly revenue history and growth rate from 2023 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Caris Life Sciences, Inc. revenue for the quarter ending March 31, 2026 was 216.2 M, a 78.78% increase year-over-year.
- Caris Life Sciences, Inc. revenue for the twelve months ending March 31, 2026 was 735.3 M.
- Caris Life Sciences, Inc. annual revenue for 2025 was 812.0 M, a 96.97% increase from 2024.
- Caris Life Sciences, Inc. annual revenue for 2024 was 412.3 M, a 34.67% increase from 2023.
- Caris Life Sciences, Inc. annual revenue for 2023 was 306.1 M.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Caris Life Sciences, Inc. Earnings — FAQ
Caris Life Sciences, Inc. (CAI) earnings over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CAI's earnings history?
The chart and table above show Caris Life Sciences, Inc.'s earnings by year and by quarter, including the growth rate.